药品注册申请号:091526
申请类型:ANDA (仿制药申请)
申请人:FRESENIUS KABI USA
申请人全名:FRESENIUS KABI USA LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE DIPHENHYDRAMINE HYDROCHLORIDE INJECTABLE;INJECTION 50MG/ML No No AP 2013/03/26 2013/03/26 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2013/03/26 ORIG-1(原始申请) Approval Not Applicable
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:DIPHENHYDRAMINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:50MG/ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
080817 002 ANDA DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE INJECTABLE;INJECTION 50MG/ML Prescription Yes Yes AP Approved Prior to Jan 1, 1982 WEST-WARD PHARMS INT
040466 001 ANDA DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE INJECTABLE;INJECTION 50MG/ML Prescription No No AP 2002/05/28 APP PHARMS
040498 001 ANDA DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE INJECTABLE;INJECTION 50MG/ML Prescription No Yes AP 2005/07/12 MYLAN INSTITUTIONAL
091526 001 ANDA DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE DIPHENHYDRAMINE HYDROCHLORIDE INJECTABLE;INJECTION 50MG/ML Prescription No No AP 2013/03/26 FRESENIUS KABI USA
205723 001 ANDA DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE INJECTABLE;INJECTION 50MG/ML Prescription No No AP 2018/08/22 MICRO LABS
218448 001 ANDA DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE INJECTABLE;INJECTION 50MG/ML Prescription No No AP 2024/03/20 GLAND PHARMA LTD
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database